Clinical trial
Aminocamptothecin in Treating Patients With Stomach Cancer or Cancer of the…
NCT00003192 · University of Chicago, Other · Completed
Key facts
| NCT number | NCT00003192 |
|---|---|
| Title | Aminocamptothecin in Treating Patients With Stomach Cancer or Cancer of the Esophagus |
| Official title | A Phase II Trial of 9-Aminocamptothecin (NSC 603071) Administered as a 120-Hour Continuous Infusion in Patients With Previously Untreated Gastric Cancer |
| Lead sponsor | University of Chicago, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer, Gastric Cancer |
| Intervention type | Drug |
| Interventions | aminocamptothecin |
| Enrollment | 15 |
| Start date | Mar 1, 1998 |
| Primary completion | Feb 1, 2002 |
| Completion | Aug 1, 2003 |
| First posted | Mar 30, 2004 |
| Last update posted | Sep 5, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: